Repronex

Active Ingredient(s): Menotropins
FDA Approved: * August 27, 1999
Pharm Company: * FERRING
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Repronex Overview

Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women.[1] Contents 1 Description and usage 2 List of hMG preparations 3 See also 4 References Description and usage Urine of postmenopausal women reflects the hypergonadotropic state of menopau...

Read more Repronex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Menotropin

Recent Repronex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Menotropins
  • Injection: 150 Iu/amp, 150 iu/amp + 150 iu/amp, 150 Iu/vial, 150 iu/vial + 150 iu/vial, 150IU, 300IU, 75 Iu/amp, 75 iu/amp + 75 iu/amp, 75 Iu/vial, 75 iu/vial + 75 iu/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Repronex: (1 result)

Sorted by National Drug Code
  • 55566-7185 Repronex Intramuscular; Subcutaneous Kit by Ferring Pharmaceuticals

Other drugs which contain Menotropins or a similar ingredient: (4 results)

Related Repronex Topics:

REPRONEX INJECTION
USED FOR INFERTILITY...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA